Trial intelligence / Profile preview

Epelsiban PK and Safety in Healthy Women

NCT02703181Phase 1Completed

Sponsor
GSK
Start
Jul 2015
Primary completion
Sep 2015
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in infertility comparing Epelsiban Arm with Placebo Arm (2 arms). Primary endpoints: Area under the concentration versus time from time zero to infinite time at Day 14, Area under the concentration versus time from time zero to last time point with measurable concentration at Day 14 and 10 more. Started Jul 2015; status: completed.

02

Drugs

epelsiban
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02703181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02703181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call